BTIG Research Initiates Coverage on Pacira Biosciences (NASDAQ:PCRX)
BTIG Research initiated coverage on shares of Pacira Biosciences (NASDAQ:PCRX) in a report issued on Wednesday, Briefing.com Automated Import reports. The brokerage issued a buy rating and a $56.00 price objective on the stock.
Several other brokerages have also recently issued reports on PCRX. BMO Capital Markets reduced their price target on shares of Pacira Biosciences from $46.00 to $43.00 and set a market perform rating on the stock in a research report on Friday, August 9th. BidaskClub cut shares of Pacira Biosciences from a hold rating to a sell rating in a report on Thursday, October 3rd. Stifel Nicolaus set a $42.00 price objective on shares of Pacira Biosciences and gave the stock a hold rating in a report on Friday, August 9th. Jefferies Financial Group set a $60.00 price obj ...